MRCP2-1233

A 47-year-old woman comes to the Medical Outpatient Clinic seeking advice. She has been taking atenolol for hypertension for the past two years. During her visit, she asks about hormone replacement therapy (HRT) as she suspects she may be going through menopause due to hot flashes, mood swings, and missed periods for the past six months. She has no history of thromboembolism, stroke, or breast cancer, but is concerned about the conflicting information she has read in the media regarding the risks of HRT, particularly in relation to deep venous thrombosis (DVT) and heart disease. What is the correct statement regarding combined oestrogen-progestin therapy for HRT?